Hendrik Gerhardus Kruger, PhD
Affiliations: | 1996- | Pharmaceutical Chemistry | University of KwaZulu-Natal, Berea, KwaZulu-Natal, South Africa |
Area:
Organic synthesisWebsite:
http://cpru.ukzn.ac.za/Homepage.aspxGoogle:
"Hendrik G Kruger"Mean distance: 11.26 | S | N | B | C | P |
Parents
Sign in to add mentor| Agatha M. Viljoen | grad student | 1976- | Potchefstroom University |
| Frans Johannes Cornelius | grad student | 1992-1996 | chemistry |
Children
Sign in to add traineeCollaborators
Sign in to add collaborator| Vincent Bisetty | collaborator | 2002- | |
| Per I Arvidsson | collaborator | 2007- | |
| Thavendran Govender | collaborator | 2008- | |
| Tricia Naicker | collaborator | 2008- | |
| Maya Makatini | collaborator | 2010- | |
| Oluseye Kehinde Onajole | collaborator | 2012- | |
| Gyanu Lamichhane | collaborator | 2015- | |
| Sibusiso Maseko | collaborator | 2020- |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Naidoo V, Mdanda S, Ntshangase S, et al. (2023) Corrigendum to "Brain penetration of ketamine: Intranasal delivery VS parenteral routes of administration" [J. Psychiatr. Res. 112 (2019) 7-11]. Journal of Psychiatric Research. 165: 254 |
| Shungube M, Hlophe AK, Girdhari L, et al. (2023) Synthesis and biological evaluation of novel β-lactam-metallo β-lactamase inhibitors. Rsc Advances. 13: 18991-19001 |
| Reddy N, Girdhari L, Shungube M, et al. (2023) Neutralizing Carbapenem Resistance by Co-Administering Meropenem with Novel β-Lactam-Metallo-β-Lactamase Inhibitors. Antibiotics (Basel, Switzerland). 12 |
| Peters BK, Reddy N, Shungube M, et al. (2023) In Vitro and In Vivo Development of a β-Lactam-Metallo-β-Lactamase Inhibitor: Targeting Carbapenem-Resistant . Acs Infectious Diseases |
| Omolabi KF, Reddy N, Mdanda S, et al. (2023) The in vitro and in vivo potential of metal-chelating agents as metallo-beta-lactamase inhibitors against carbapenem-resistant Enterobacterales. Fems Microbiology Letters. 370 |
| Martins LS, Kruger HG, Naicker T, et al. (2022) Computational insights for predicting the binding and selectivity of peptidomimetic plasmepsin IV inhibitors against cathepsin D. Rsc Advances. 13: 602-614 |
| du Preez HN, Aldous C, Kruger HG, et al. (2022) N-Acetylcysteine and Other Sulfur-Donors as a Preventative and Adjunct Therapy for COVID-19. Advances in Pharmacological and Pharmaceutical Sciences. 2022: 4555490 |
| Gouws AC, Kruger HG, Gheysens O, et al. (2022) Antibiotic-Derived Radiotracers for Positron Emission Tomography: Nuclear or 'Unclear' Infection Imaging? Angewandte Chemie (International Ed. in English) |
| du Preez HN, Aldous C, Hayden MR, et al. (2022) Pathogenesis of COVID-19 described through the lens of an undersulfated and degraded epithelial and endothelial glycocalyx. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 36: e22052 |
| Silva JRA, Kruger HG, Molfetta FA. (2021) Drug repurposing and computational modeling for discovery of inhibitors of the main protease (M) of SARS-CoV-2. Rsc Advances. 11: 23450-23458 |